Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly M Chin

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 2, 2024
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON studyRaymond L Benza, Kelly M Chin, Sean Gaine, et al.
The American Journal of Cardiology|April 2, 2013
Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertensionMariella Vélez-Martínez, Colby Ayers, Joseph D Mishkin, et al.
Chest|March 12, 2026
How I do it: How to care for the patient with methamphetamine-associated PAHNicholas A Kolaitis, Christopher F Barnett, Kelly M Chin, et al.
European Heart Journal|July 12, 2012
Left atrial structure and function and clinical outcomes in the general populationSachin Gupta, Susan A Matulevicius, Colby R Ayers, et al.
Pulmonary Circulation|February 19, 2026
Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER StudyLuke S Howard, David G Kiely, Allan Lawrie, et al.
Pulmonary Circulation|November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
Journal of the American College of Cardiology|December 21, 2013
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiologyAnton Vonk-Noordegraaf, François Haddad, Kelly M Chin, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]Anton Vonk-Noordegraaf, François Haddad, Kelly M Chin, et al.
Chest|February 5, 2021
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON StudySean Gaine, Olivier Sitbon, Richard N Channick, et al.
European Journal of Heart Failure|July 5, 2024
Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbiditiesVallerie V McLaughlin, Olivier Sitbon, Kelly M Chin, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 2, 2024
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON studyRaymond L Benza, Kelly M Chin, Sean Gaine, et al.
The American Journal of Cardiology|April 2, 2013
Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertensionMariella Vélez-Martínez, Colby Ayers, Joseph D Mishkin, et al.
Chest|March 12, 2026
How I do it: How to care for the patient with methamphetamine-associated PAHNicholas A Kolaitis, Christopher F Barnett, Kelly M Chin, et al.
European Heart Journal|July 12, 2012
Left atrial structure and function and clinical outcomes in the general populationSachin Gupta, Susan A Matulevicius, Colby R Ayers, et al.
Pulmonary Circulation|February 19, 2026
Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER StudyLuke S Howard, David G Kiely, Allan Lawrie, et al.
Pulmonary Circulation|November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
Journal of the American College of Cardiology|December 21, 2013
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiologyAnton Vonk-Noordegraaf, François Haddad, Kelly M Chin, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]Anton Vonk-Noordegraaf, François Haddad, Kelly M Chin, et al.
Chest|February 5, 2021
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON StudySean Gaine, Olivier Sitbon, Richard N Channick, et al.
European Journal of Heart Failure|July 5, 2024
Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbiditiesVallerie V McLaughlin, Olivier Sitbon, Kelly M Chin, et al.
Pageof 7